JAMA Network Open Analysis Associates Earlier Menopause With Faster White Matter Hyperintensity Growth and 1.8-Year Earlier Alzheimer's Diagnosis

The JAMA Network Open study combined three datasets: longitudinal cognitive testing in 2,603 women, autopsy neuropathology in 1,253, and serial MRI in 774. Earlier age at menopause correlated with steeper episodic memory decline, accelerated late-life brain atrophy, and earlier clinical Alzheimer's onset after adjustment for education, vascular risk, and APOE status. Spontaneous menopause showed dose-dependent white matter hyperintensity increases, whereas surgical menopause did not, suggesting abrupt estrogen withdrawal may trigger distinct pathways. The average diagnosis age of 88.4 years translated to a 2% faster onset per decade of earlier menopause. Estrogen's roles in mitochondrial function, inflammation control, and synaptic maintenance provide a plausible mechanism, yet the study could not separate endogenous timing from unmeasured socioeconomic or genetic confounders. Prior observational data from the Women's Health Initiative Memory Study and ELITE trial indicate that hormone therapy started within five years of menopause may attenuate some structural changes, a signal absent in late initiation. These patterns imply a critical window rather than lifelong protection. Next, adequately powered randomized trials must test whether early, individualized hormone regimens slow white matter progression and delay clinical onset by measurable thresholds within five to ten years.